Видео ютуба по тегу Amgen

The Amgen Difference - Our People, Our Values
The Amgen Difference - Our People, Our Values
Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond
Wait for longer-term data with Amgen's GLP-1, says Piper Sandler's Christopher Raymond
Rory McIlroy | Round 2 Highlights | 2024 Amgen Irish Open
Rory McIlroy | Round 2 Highlights | 2024 Amgen Irish Open
Cell Culture and Expansion - Biotech Manufacturing at Amgen
Cell Culture and Expansion - Biotech Manufacturing at Amgen
Amgen: How Biotechnology is Transforming Medicine
Amgen: How Biotechnology is Transforming Medicine
Working at Amgen
Working at Amgen
How Amgen is using Generative Biology and AI
How Amgen is using Generative Biology and AI
Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen
Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen
Cramer’s Mad Dash: Amgen
Cramer’s Mad Dash: Amgen
Cramer’s Stop Trading: Amgen
Cramer’s Stop Trading: Amgen
Amgen CFO talks Q2 earnings, obesity drug, and growth
Amgen CFO talks Q2 earnings, obesity drug, and growth
Amgen, A Five Minute History
Amgen, A Five Minute History
The Next Generation of Biomanufacturing at Amgen
The Next Generation of Biomanufacturing at Amgen
Chart of the Day: Amgen
Chart of the Day: Amgen
Amgen sinks as Cantor flags issues with obesity drug
Amgen sinks as Cantor flags issues with obesity drug
Amgen Oncology 360 VR Pipeline Experience
Amgen Oncology 360 VR Pipeline Experience
Amgen: Are Its Golden Days Over? | FAST Graphs
Amgen: Are Its Golden Days Over? | FAST Graphs
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Amgen shares fall on anti-obesity drug | REUTERS
Amgen shares fall on anti-obesity drug | REUTERS